Moore Capital Management LP boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 29.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 134,686 shares of the medical technology company’s stock after acquiring an additional 30,255 shares during the quarter. Moore Capital Management LP’s holdings in Teleflex were worth $16,437,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the business. Janus Henderson Group PLC increased its holdings in Teleflex by 2.0% during the fourth quarter. Janus Henderson Group PLC now owns 4,246,112 shares of the medical technology company’s stock valued at $518,196,000 after buying an additional 84,754 shares during the period. Evolve Private Wealth LLC acquired a new position in shares of Teleflex during the fourth quarter worth $567,000. Empyrean Capital Partners LP purchased a new stake in shares of Teleflex during the 4th quarter valued at $14,401,000. Balyasny Asset Management L.P. purchased a new stake in shares of Teleflex during the 4th quarter valued at $10,702,000. Finally, Freestone Grove Partners LP lifted its holdings in shares of Teleflex by 12.3% during the 4th quarter. Freestone Grove Partners LP now owns 200,939 shares of the medical technology company’s stock valued at $24,523,000 after purchasing an additional 22,035 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several analysts have recently commented on TFX shares. Mizuho set a $140.00 price objective on Teleflex in a report on Friday, May 8th. Raymond James Financial reiterated an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $140.00 to $160.00 in a report on Monday, June 8th. Truist Financial reiterated a “hold” rating and set a $143.00 price objective (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Finally, Royal Bank Of Canada upgraded Teleflex from a “sector perform” rating to an “outperform” rating and increased their price objective for the company from $135.00 to $155.00 in a report on Friday, May 8th. Four equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $146.00.
Teleflex Trading Down 2.2%
NYSE:TFX opened at $125.08 on Thursday. Teleflex Incorporated has a 12 month low of $100.18 and a 12 month high of $139.67. The firm has a fifty day simple moving average of $129.31 and a 200-day simple moving average of $119.24. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The company has a market capitalization of $5.54 billion, a P/E ratio of -5.49, a PEG ratio of 0.95 and a beta of 0.82.
Teleflex (NYSE:TFX – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business had revenue of $548.30 million during the quarter, compared to the consensus estimate of $536.91 million. During the same period in the previous year, the firm posted $1.44 earnings per share. The business’s revenue for the quarter was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities research analysts anticipate that Teleflex Incorporated will post 6.7 earnings per share for the current year.
Teleflex Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Friday, May 22nd. Teleflex’s payout ratio is presently -5.96%.
Teleflex Profile
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
See Also
- Five stocks we like better than Teleflex
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
